NEW YORK, October 9, 2017 /PRNewswire/ --
If you want a Stock Review on ESRX, AET, CI, or ANTM then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. This morning,
DailyStockTracker.com covers the Health Care Plans industry, which offers health benefit plans to employers and individuals. Most
companies in this space offer below-average dividend yields. Lined up for scanning are the following equities: Express Scripts
Holding Co. (NASDAQ: ESRX), Aetna Inc. (NYSE: AET), Cigna Corp. (NYSE: CI), and Anthem Inc. (NYSE: ANTM). Daily Stock Tracker
published free research reports on these stocks today at:
http://dailystocktracker.com/register/
Express Scripts Holding
Saint Louis, Missouri headquartered Express Scripts Holding Co.'s stock saw a correction of
2.58%, finishing last Friday's trading session at $62.36. A total volume of 4.77 million shares was
traded, which was above their three months average volume of 3.06 million shares. The Company's shares have gained 0.03% in the
last month and 0.86% over the previous three months. The stock is trading above its 50-day moving average by 0.34%. Additionally,
shares of Express Scripts, which operates as a pharmacy benefit management company in the US, Canada, and Europe, have a Relative Strength Index (RSI) of 47.70.
On September 19 th, 2017, research firm RBC Capital Markets initiated a 'Sector
Perform' rating on the Company's stock, with a target price of $68 per share.
On October 02 nd, 2017, Express Scripts introduced a new Express Scripts
Medicare® Prescription Drug Plan for 2018 called the Saver plan, a low-premium Part D plan that provides
affordable access to nearly 3,000 commonly used medications and a preferred pharmacy network with CVS Pharmacy and the Kroger
Family of Pharmacies.See our free and comprehensive research report on ESRX at:
http://dailystocktracker.com/registration/?symbol=ESRX
Aetna
Shares in Hartford, Connecticut-based Aetna Inc. ended at $161.28, down 0.01% from the last trading session. The stock recorded a trading volume of 993,378 shares. The
Company's shares have advanced 0.64% in the past month, 4.70% over the previous three months, and 30.05% since the start of this
year. The stock is trading 2.57% and 14.48% above its 50-day and 200-day moving averages, respectively. Moreover, shares of
Aetna, which operates as a health care benefits company in the US, have an RSI of 58.37.
On September 29 th, 2017, Aetna's Board of Directors declared a quarterly cash
dividend of $0.50 per share on its common stock. The dividend is payable on October 27 th, 2017, to shareholders of record at the close of business on October 12 th, 2017. AET free research report is just a click away at:
http://dailystocktracker.com/registration/?symbol=AET
Cigna
On Friday, shares in Bloomfield, Connecticut headquartered Cigna Corp. recorded a trading
volume of 879,649 shares. The stock rose 0.14%, closing the day at $190.95. The Company's shares
have gained 3.23% in the last one month, 12.61% over the previous three months, and 43.15% on an YTD basis. The stock is trading
5.44% above its 50-day moving average and 18.11% above its 200-day moving average. Additionally, shares of Cigna, which provides
insurance and related products and services in the US and internationally, have an RSI of 65.94.
On October 04 th, 2017, Cigna announced that it will release its Q3 2017 financial
results on November 02 nd, 2017, no later than 6:30 a.m.
EDT. Management will review these results on a conference call beginning at 8:30 a.m. EDT
that same morning. The conference call will be webcast live under the Investor Relations section of the Company's website.
Sign up for your complimentary report on CI at:
http://dailystocktracker.com/registration/?symbol=CI
Anthem
At the close of trading on Friday, shares in Indianapolis, Indiana headquartered Anthem Inc.
recorded a trading volume of 848,050 shares. The stock finished the session 0.16% higher at $193.22. The Company's shares have gained 0.30% in the past month, 0.57% in the previous three months, and
34.40% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 1.53% and 10.08%,
respectively. Furthermore, shares of Anthem, which through its subsidiaries, operates as a health benefits company in the US,
have an RSI of 58.62.
On September 20 th, 2017, Anthem announced that it has entered into an agreement to
acquire HealthSun, one of the fastest-growing integrated Medicare Advantage health plans and healthcare delivery networks in
Florida. The acquisition is expected to close by the end of 2017, subject to approvals from
state and federal regulatory authorities, standard closing conditions, and customary approvals. Register for free on
DailyStockTracker.com and download the latest research report on ANTM at:
http://dailystocktracker.com/registration/?symbol=ANTM
--
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent
departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES :
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email contact@dailystocktracker.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"),
provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary,
based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a
reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the
information herein. The Reviewer has only independently reviewed the information provided by the Author according to the
procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party
research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside
of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://dailystocktracker.com/disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you ' re
a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between
09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: contact@dailystocktracker.com
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE dailystocktracker.com